Polishing the Gold Standard in Prostate Cancer October 20, 2019 When Howard Wolinsky, 72, received a prostate cancer diagnosis in 2010, the urologist at a community hospital wasted no time in presenting him with a range of treatment options: surgery, radiation and cryotherapy (freezing tissue to destroy it). The biopsy had revealed just a small lesion of low-grade cancer in one of 12 zones, or sectors, of the prostate gland, but Wolinsky’s doctor was among many at the time who did not yet recommend active surveillance as a less-invasive alternative for men with low-risk prostate cancer.Fortunately, Wolinsky, a Chicago journalist, was well-informed and knew that the University of Chicago had an active surveillance program.Read the full story here.Source: Marilyn Fenichel - CURE Today Prostate Cancer News
When Howard Wolinsky, 72, received a prostate cancer diagnosis in 2010, the urologist at a community hospital wasted no time in presenting him with a range of treatment options: surgery, radiation and cryotherapy (freezing tissue to destroy it). The biopsy had revealed just a small lesion of low-grade cancer in one of 12 zones, or sectors, of the prostate gland, but Wolinsky’s doctor was among many at the time who did not yet recommend active surveillance as a less-invasive alternative for men with low-risk prostate cancer.Fortunately, Wolinsky, a Chicago journalist, was well-informed and knew that the University of Chicago had an active surveillance program.Read the full story here.Source: Marilyn Fenichel - CURE Today
